7XRR image
Deposition Date 2022-05-11
Release Date 2022-11-23
Last Version Date 2024-11-06
Entry Detail
PDB ID:
7XRR
Title:
Crystal structure of the human OX2R bound to the insomnia drug lemborexant.
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.89 Å
R-Value Free:
0.28
R-Value Work:
0.27
R-Value Observed:
0.27
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Orexin receptor type 2
Gene (Uniprot):HCRTR2
Chain IDs:A
Chain Length:341
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Molecular basis for anti-insomnia drug design from structure of lemborexant-bound orexin 2 receptor.
Structure 30 1582 1589.e4 (2022)
PMID: 36417909 DOI: 10.1016/j.str.2022.11.001

Abstact

Orexin receptors are a family of G protein-coupled receptors that consist of two subtypes: orexin-1 receptors (OX1Rs) and OX2Rs. They are expressed throughout the central nervous system and are involved in regulating the sleep-wake cycle. The development of antagonists to orexin receptors has become important in drug discovery because modulation of these receptors can lead to novel treatments for diseases related to the regulation of sleep and wakefulness, such as insomnia. In this study, we determined that the structure of OX2R bound to lemborexant, a dual orexin receptor antagonist (DORA), at 2.89 Å resolution. Comparisons of kinetic and dynamic properties of DORAs based on structures and simulations suggest that the enthalpy of molecular binding to receptors and the entropy derived from intramolecular structure can be separately controlled. These results complement existing structural information and allow us to discuss the usefulness of pharmacophore models and target selectivity to OXRs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures